Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3815-3824
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3815
Table 2 Association between IFNL3 (IL28B) single nucleotide polymorphism and sustained virological response after pegylated interferon alpha and ribavirin treatment in chronic hepatitis C patients
SNPAllele/genotypeResponse (n = 54), n (%)Non-response (n = 126), n (%)Response vs non-responseORcrude (95%CI)/ORadjusted (95%CI)1Pcrude/Padjusted1
rs4803217 (C/A)C/A85 (78.70)/23 (21.30)109 (43.25)/143 (56.75)C/A4.848 (2.871-8.186)< 0.0001a
CC34 (62.96)14 (11.11)CC/CA + AA13.6 (6.219-29.770)/8.357 (3.013-23.181)< 0.0001a/< 0.0001a
CA17 (31.48)81 (64.29)CC + CA/AA5.547 (1.617-19.035)/3.240 (0.849-12.367)0.003a/0.082
AA3 (55.56)31 (24.60)Dose of C allele7.588 (3.858-14.922)/4.310 (1.956-9.500)< 0.0001a/0.0002a
rs12979860 (C/T)C/T82 (75.93)/26 (24.07)108 (42.86)/144 (57.14)C/T4.205 (2.533-6.980)< 0.0001a
CC32 (59.26)14 (11.11)CC/CT + TT11.636 (5.351-25.306)/9.765 (3.407-27.990)< 0.0001a/< 0.0001a
CT18 (33.33)80 (63.49)CC + CT/TT4.255 (1.424-12.715)/4.413 (0.927-21.011)0.006a/0.059
TT4 (7.41)32 (25.40)Dose of C allele6.072 (3.195-11.538)/5.574 (2.345-13.246)< 0.0001a/< 0.0001a
rs8099917 (T/G)T/G80 (74.07)/28 (25.93)149 (59.13)/103 (40.87)T/G1.975 (1.2-3.251)0.007a
TT29 (53.70)39 (30.95)TT/TG + GG2.588 (1.344-4.981)/2.097 (0.844-5.210)0.004a/0.107
TG22 (40.74)71 (56.35)TT + TG/GG2.473 (0.690-8.867)/2.397 (0.482-11.926)0.153/0.280
GG3 (5.56)16 (12.70)Dose of T allele2.190 (1.266-3.788)/1.869 (0.911-3.837)0.0048a/0.0845
rs12980275 (A/G)A/G85 (78.70)/23 (21.30)120 (47.62)/132 (52.38)A/G4.065 (2.410-6.857)< 0.0001a
AA35 (64.81)23 (18.25)AA/AG + GG8.249 (4.021-16.923)/5.225 (1.999-13.658)< 0.0001a/0.001a
AG15 (27.78)74 (58.73)AA + AG/GG3.737 (1.244-11.223)/4.075 (0.848-19.589)0.013a/0.076
GG4 (7.41)29 (23.02)Dose of A allele4.705 (2.591-8.542)/3.596 (1.659-7.791)< 0.0001a/0.001a